About Antidote
Antidote Technologies is a precision recruitment company on a mission to catalyze medical innovation by successfully connecting patients and researchers. The company addresses a critical problem in medical research: more than 80% of clinical studies are delayed due to lack of participants. Antidote solves this through two complementary approaches. For pharmaceutical sponsors and life science companies, they provide precision recruitment services using digital marketing, AI-powered patient matching, and a network of 300+ healthcare partners to accelerate enrollment. For patients, they've built the Match search engine—a smart platform that makes finding relevant clinical trials easy and accessible. The company brings together professionals with pharmaceutical, technology, business, and public health backgrounds to achieve their mission. Antidote operates with a patient-first mindset and maintains strong commitments to diversity, equity, and inclusion in clinical trial populations, as well as environmental, social, and corporate governance. They've received the Silver Award from Ecovadis for two consecutive years, placing them in the top 25% of companies assessed for corporate social responsibility. Through partnerships with organizations like JDRF, MSAA, BrightFocus Foundation, Beyond Type 1, and Melanoma Research Alliance, Antidote provides dynamic content and trial search tools to patient communities while helping researchers find the volunteers they need for breakthrough treatments.
Mission & Story
Mission
Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies.
Clinical Focus
Medical conditions and clinical areas addressed by Antidote.
Who It Serves
Milestones & Awards
Recent Milestones
Partnership with SEQSTER announced in 2024 for patient matching and real-time data access. Launched first-ever Spanish-language clinical trial search engine for type 1 diabetes with Beyond Type 1 and JDRF. Received Ecovadis Silver Award for two consecutive years (2022, 2023).
Awards & Recognition
Ecovadis Silver Award (2022, 2023) - top 25% of 90,000 companies for corporate social responsibility. High marks in cybersecurity risk assessment.
Key Partnerships
Social & Media
Latest Updates
Eight Months and $30,000 Before Subject Enrollment: The Real Price of Another Site
1w ago
Your Enrollment Problem Isn't a Site-Selection Problem. Here’s Why.
2w ago
Have You Got Real-World Insights Before Study Launch?
4w ago
Are Real-Time Trials Leaving Recruitment Behind?
1mo ago
Why Hypertension Trials Are No Longer Just About Blood Pressure
2mo ago
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Clario
Clario provides digital endpoint technology and evidence generation solutions for clinical trials. The company offers cardiac safety, eCOA, medical imaging, precision motion, and respiratory solutions to pharmaceutical, biotech, and CRO clients across all trial phases.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.